Private pharmaceutical R&D spending in the U.S. is around $100bn per year [1]. NIH spends another $50bn a year on biomedical research [2].
That eclipses total investments into adtech per se, which generously counted shouldn’t exceed $50 to 60bn. (And that only by counting like a third to a half of Google, Amazon, et cetera R&D and capital spending as adtech.) More precisely counted, it probably doesn’t exceed $10bn.
[1] https://phrma.org/blog/phrma-member-companies-rd-investments...
[2] https://www.science.org/content/article/final-nih-budget-202...
As a result, life science researchers are more price-taking than proce-setting when it comes to their wages / salary. If money is the motivator, then the market as-is isn’t addressing this one.
Also wonder, outside of politics and economics, whether there's a social and cultural component that can contribute. TV shows, movies, books, and other forms of media that put science and scientists in the spotlight in a positive light can be tremendously inspirational.
Adtech works because there is a lot of money in it. There is a lot of money in it because people seek quick entertainment, and we have a LOT of people driving the demand.
Now compare that to cancer research. There's no short term gratification about it.
There's a wide world outside big tech, Silicon Valley, and software in general. It only tends to be a bit less visible online.
And even more brilliant minds are defeating it, every day. I have doubts about how useful they would be in a research lab.